Correction to : A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
| Errataetall: |
ErratumFor: Cancer Chemother Pharmacol. 2023 Apr;91(4):291-300. - PMID 36738333 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:91 |
|---|---|
| Enthalten in: |
Cancer chemotherapy and pharmacology - 91(2023), 4 vom: 26. Apr., Seite 301 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kim, Richard [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 05.04.2023 published: Print ErratumFor: Cancer Chemother Pharmacol. 2023 Apr;91(4):291-300. - PMID 36738333 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s00280-023-04522-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354724665 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354724665 | ||
| 003 | DE-627 | ||
| 005 | 20231226062831.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00280-023-04522-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1182.xml |
| 035 | |a (DE-627)NLM354724665 | ||
| 035 | |a (NLM)36967405 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kim, Richard |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.04.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Cancer Chemother Pharmacol. 2023 Apr;91(4):291-300. - PMID 36738333 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Leal, Alexis D |e verfasserin |4 aut | |
| 700 | 1 | |a Parikh, Aparna |e verfasserin |4 aut | |
| 700 | 1 | |a Ryan, David P |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Shining |e verfasserin |4 aut | |
| 700 | 1 | |a Bahamon, Brittany |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Neeraj |e verfasserin |4 aut | |
| 700 | 1 | |a Moss, Aaron |e verfasserin |4 aut | |
| 700 | 1 | |a Pye, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Miao, Harry |e verfasserin |4 aut | |
| 700 | 1 | |a Inguilizian, Haig |e verfasserin |4 aut | |
| 700 | 1 | |a Cleary, James M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer chemotherapy and pharmacology |d 1990 |g 91(2023), 4 vom: 26. Apr., Seite 301 |w (DE-627)NLM00036438X |x 1432-0843 |7 nnns |
| 773 | 1 | 8 | |g volume:91 |g year:2023 |g number:4 |g day:26 |g month:04 |g pages:301 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00280-023-04522-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 91 |j 2023 |e 4 |b 26 |c 04 |h 301 | ||